BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21969188)

  • 1. Guest editorial: a new era of ATL and HTLV-1 research.
    Matsuoka M
    Int J Hematol; 2011 Nov; 94(5):429. PubMed ID: 21969188
    [No Abstract]   [Full Text] [Related]  

  • 2. The state of the art in the pathogenesis of ATL and new potential targets associated with HTLV-1 and ATL.
    Murata K; Yamada Y
    Int Rev Immunol; 2007; 26(5-6):249-68. PubMed ID: 18027200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent progress in ATL and HTLV-1 research].
    Matsuoka M
    Rinsho Ketsueki; 2008 Oct; 49(10):1508-14. PubMed ID: 18833935
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanism of leukemogenesis by human T-cell leukemia virus type I: from infection with HTLV-I to the onset of adult T-cell leukemia].
    Matsuoka M
    Rinsho Ketsueki; 2006 Dec; 47(12):1493-501. PubMed ID: 17233467
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular pathogenesis by human T-cell leukemia virus type 1].
    Matsuoka M
    Rinsho Ketsueki; 2011 May; 52(5):256-62. PubMed ID: 21646770
    [No Abstract]   [Full Text] [Related]  

  • 6. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells.
    Satou Y; Yasunaga J; Yoshida M; Matsuoka M
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):720-5. PubMed ID: 16407133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the HBZ gene represent a new potential target for the treatment of adult T-cell leukemia?
    Barbeau B; Mesnard JM
    Int Rev Immunol; 2007; 26(5-6):283-304. PubMed ID: 18027202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential for molecular targeted therapy for adult T-cell leukemia/lymphoma.
    Faris M
    Int Rev Immunol; 2008; 27(1-2):71-8. PubMed ID: 18300056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation.
    Narita T; Ishida T; Masaki A; Suzuki S; Ito A; Mori F; Yamada T; Ri M; Kusumoto S; Komatsu H; Miyazaki Y; Takatsuka Y; Utsunomiya A; Niimi A; Iida S; Ueda R
    J Immunol; 2014 Feb; 192(3):940-7. PubMed ID: 24363428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of HTLV-1 persistence and transformation.
    Boxus M; Willems L
    Br J Cancer; 2009 Nov; 101(9):1497-501. PubMed ID: 19861996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adult T-cell leukemia induced by HTLV-1: before and after HBZ].
    Duc Dodon M; Mesnard JM; Barbeau B
    Med Sci (Paris); 2010 Apr; 26(4):391-6. PubMed ID: 20412744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells.
    Takachi T; Takahashi M; Takahashi-Yoshita M; Higuchi M; Obata M; Mishima Y; Okuda S; Tanaka Y; Matsuoka M; Saitoh A; Green PL; Fujii M
    Cancer Sci; 2015 Apr; 106(4):461-5. PubMed ID: 25613934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HBZ gene, a key player in HTLV-1 pathogenesis.
    Matsuoka M; Green PL
    Retrovirology; 2009 Aug; 6():71. PubMed ID: 19650892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of ATL: an odyssey in restrospect.
    Yodoi J; Maeda M
    Int J Hematol; 2011 Nov; 94(5):423-8. PubMed ID: 22068231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5' long terminal repeat during oncogenesis.
    Miyazaki M; Yasunaga J; Taniguchi Y; Tamiya S; Nakahata T; Matsuoka M
    J Virol; 2007 Jun; 81(11):5714-23. PubMed ID: 17344291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody therapy for Adult T-cell leukemia-lymphoma.
    Ishida T; Ueda R
    Int J Hematol; 2011 Nov; 94(5):443-52. PubMed ID: 21993874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell analysis of T-cell receptor repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma.
    Tanaka Y; Nakasone H; Yamazaki R; Sato K; Sato M; Terasako K; Kimura S; Okuda S; Kako S; Oshima K; Tanihara A; Nishida J; Yoshikawa T; Nakatsura T; Sugiyama H; Kanda Y
    Cancer Res; 2010 Aug; 70(15):6181-92. PubMed ID: 20647322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological risks of adult T-cell leukemia at primary HTLV-I infection.
    Kannagi M; Ohashi T; Harashima N; Hanabuchi S; Hasegawa A
    Trends Microbiol; 2004 Jul; 12(7):346-52. PubMed ID: 15223062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV-1 bZIP factor dysregulates the Wnt pathways to support proliferation and migration of adult T-cell leukemia cells.
    Ma G; Yasunaga J; Fan J; Yanagawa S; Matsuoka M
    Oncogene; 2013 Sep; 32(36):4222-30. PubMed ID: 23045287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in adult T-cell leukemia (ATL) in non-ATL-endemic Hokkaido of Japan.
    Iwanaga M; Takada K; Fujiwara S; Oikawa O; Sugiura M; Imai S; Osato T; Mikuni C; Maekawa I; Miyazaki T
    In Vivo; 1994; 8(6):1007-10. PubMed ID: 7772727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.